Epstein-Barr Virus: Forgotten Etiology of Hepatic Injury
Epstein-Barr virus infection may present with liver injury characterized by acute cholestatic hepatitis, as demonstrated in this case.
Epstein-Barr virus infection may present with liver injury characterized by acute cholestatic hepatitis, as demonstrated in this case.
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
In multivariate analysis, age, albumin concentration, T2DM independently tied to progression.
Prevalence of alcoholic fatty liver disease remained relatively unchanged from 2001 to 2016, but alcoholic fatty liver disease with fibrosis stage 2 and 3 or greater increased significantly.
More incident cases identified in intervention arm with nurse-led primary care-based liver clinics.
In a study, 24% of confiscated drug snorting straws tested positive for human blood.
Patients previously treated for HCC have a high risk of tumor recurrence in the long term.
The combination drug treats 6 strains of chronic hepatitis C.
The number of deaths associated with hepatitis C is higher than the total number of deaths resulting from 60 other infectious diseases.
The source of a patient’s liver transplant did not significantly affect rates of disease recurrence.